Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will present new clinical evidence related to its first fully ...

Outcomes from EVOLUTION 2 study include 68% time in range with no boluses Diverse multicenter feasibility study highlights the promise of future Omnipod innovation to address unmet needs, improve ...

With nationwide availability now underway, twiist reaches a meaningful milestone in Sequel’s mission to empower the diabetes community with more choice and a more personalized, customizable AID ...

Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.

Fully Closed-Loop System Feasibility Study to be presented at Insulet Symposium and in e-Poster during ATTD 2026 Real World Evidence of Settings Optimization in Omnipod 5 Users will also be shared ...

Ever wonder why your social media feed seems to “read your mind?” One minute, you’re watching a video about travel, and suddenly, your feed is filled with flight deals and hotel recommendations. It’s ...

“The Pentagon and OpenAI are saying to the public, You’re just going to have to trust us. And the public is saying, Well, we don’t.” By Kevin RooseCasey NewtonRachel CohnWhitney JonesVjeran PavicChris ...